We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...

When I was diagnosed with Parkinson’s in August 2019, a doctor told me that Sinemet (Levodopa/Carbidopa), the starter drug of ...

A new clinical practice guideline developed by the American Academy of Sleep Medicine provides updated recommendations for ...

GlobalData analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's ...

The Iowa Chapter of the American Parkinson Disease Association is holding a Parkinson education program from 1 to 3:30 p.m. Wednesday at the Fort Dodge Public Library, 424 Central Ave. The event is ...

Brendon Yee, PhD, professor and respiratory and sleep physician, Woolcock Institute of Medical Research, discusses the ...

Neurodegenerative disorders, affecting millions of individuals in the United States, create a profound societal and economic strain. The Alzheimer's Association highlights that the financial burden of ...

Parkinson's Disease has no cure. However, various treatment options can manage the symptoms and improve the quality of life of patients. Dr V.P. Singh, chairman, neurosurgery and neurosciences, ...

A disqualifying disposition essentially turns your incentive stock option into an NSO, disqualifying them from favorable tax treatment. There is no tax liability when you exercise the options and ...

Parkinson’s disease (PD) is a progressive disorder of the nervous system. It primarily affects movement but can also lead to other symptoms, significantly impacting quality of life over time.

While stops are useful, there are inherent problems that can be overcome by using options as an alternative. When you compare stops and options side by side, options have properties that are ...